Higher RRM1 expression was associated with shorter survival in non-small cell lung cancer patients treated with gemcitabine-based therapies24, but with better outcomes in malignant pleural mesothelioma patients treated using different chemotherapy regimen25. This evidence concerns the gene RRM1 and non-small cell lung carcinoma.